Eagle Pharmaceuticals (EGRX) Insider Trading & Ownership $0.55 -0.05 (-8.33%) (As of 12/20/2024 04:19 PM ET) Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Eagle Pharmaceuticals (NASDAQ:EGRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage28.90%Number OfInsiders Buying(Last 3 Years)0Number OfInsiders Selling(Last 3 Years)2Amount OfInsider Selling(Last 3 Years)$1.13 M Get EGRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Eagle Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address EGRX Insider Buying and Selling by Quarter Ad Crypto 101 MediaThe #1 Coin for November 2024Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… You can get access to the report by clicking here now… Eagle Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/1/2023Scott TarriffCEOSell10,925$13.82$150,983.50 10/2/2023Scott TarriffCEOSell9,511$15.23$144,852.53 5/15/2023Scott TarriffCEOSell15,000$21.07$316,050.00 5/11/2023Scott TarriffCEOSell15,000$20.71$310,650.00 9/6/2022Richard A EdlinDirectorSell6,800$30.99$210,732.00 (Data available from 1/1/2013 forward) EGRX Insider Trading Activity - Frequently Asked Questions Who is on Eagle Pharmaceuticals's Insider Roster? The list of insiders at Eagle Pharmaceuticals includes Richard A Edlin, and Scott Tarriff. Learn more on insiders at EGRX. What percentage of Eagle Pharmaceuticals stock is owned by insiders? 28.90% of Eagle Pharmaceuticals stock is owned by insiders. Learn more on EGRX's insider holdings. Which Eagle Pharmaceuticals insiders have been selling company stock? The following insider sold EGRX shares in the last 24 months: Scott Tarriff ($922,536.03). How much insider selling is happening at Eagle Pharmaceuticals? Insiders have sold a total of 50,436 Eagle Pharmaceuticals shares in the last 24 months for a total of $922,536.03 sold. Eagle Pharmaceuticals Key ExecutivesMr. Michael Graves (Age 61)Interim Principal Executive Officer & Executive Chairman of the Board Compensation: $160kMr. Steven B. Ratoff (Age 81)Interim CFO, Principal Accounting Officer & Director Compensation: $100kMr. Daniel O'Connor (Age 44)Executive VP, Chief Strategy Officer & Head of Corporate Development Dr. Valentin R. Curt M.D.Senior Vice President of Clinical Drug DevelopmentDr. Gaozhong Zhu Ph.D.Senior Vice President of Pharmaceutical DevelopmentMs. Debra Marie Hussain (Age 56)Senior VP & Head of Commercial Mr. Reed McClungExecutive Vice President of Oncology Business Development More Insider Trading Tools from MarketBeat Related Companies LEXX Insider Selling VYNE Insider Selling OCX Insider Selling LTRN Insider Selling ELEV Insider Selling LUMO Insider Selling MRKR Insider Selling CALC Insider Selling TPST Insider Selling OKYO Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:EGRX) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eagle Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eagle Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EGRX Stock Alerts